Cite
HARVARD Citation
Green, F. et al. (2016). A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers. Trials. 17 (1), pp. 1-13. [Online].